XY4-28976-60238
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 982 / WA
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Registered in v-safe
-
2020-12-24
Dose 1 — Pfizer-BioNTech
- 2020-12-24
-
2020-12-26
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Fatigue or tirednessAdult check-in
- 2020-12-28
- 2020-12-29
- 2020-12-30
-
2020-12-31
Survey response — 7 day, dose 1MedDRA: Fatigue, Pyrexia — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2020-12-31
Report sent to call center — 7 day, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-07
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-16
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-17
- 2021-01-18
-
2021-01-20
Survey response — 7 day, dose 2MedDRA: Headache — Feeling: Good · HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-01-26
Survey response — 14 day, dose 2MedDRA: Headache, Nausea — Feeling: FairMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-02
- 2021-02-09
-
2021-02-16
Survey response — 35 day, dose 2MedDRA: Fatigue, Pyrexia — Feeling: Poor · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-02-23
- 2021-04-13
- 2021-07-13
- 2022-01-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2020-12-31 | priority 2/3 | |
| 2021-01-13 | priority 2/3 | |
| 2021-01-16 | priority 2/3 |
Free text
Release 1
Systemic reaction (other): The fatigue and fever were similar to the day after the vaccine, in that they lasted abour three hours, then were gone.
Release 2
Systemic reaction (other): I have had a recurring headache, in the same area, at some point most days since the second vaccination. Less painful all the time. I never, ever have headaches.
Symptoms: The headache that I have only felt since rhis vaccine. I don't have it right now, but I did have it, and pretty bad nausea durinf last night.
Release 4
Symptoms: I still seem to have waves of extreme fatigue. Occasionally I have a fever during these.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release